Avalo Therapeutics Inc (NAS:AVTX)
$ 19.77 +1.42 (+7.74%) Market Cap: 1.06 Bil Enterprise Value: 660.23 Mil PE Ratio: 0 PB Ratio: 1.92 GF Score: 24/100

Avalo Therapeutics Inc at Jefferies Next Generation IBD Therapeutics Summit (Virtual) - Pre-recorded Presentation Transcript

Oct 19, 2021 / 12:00PM GMT
Release Date Price: $6451.2 (+1.36%)

Oct 19, 2021 / 12:00PM GMT
Presentation
Oct 19, 2021 / 12:00PM GMT

=====================
Corporate Participants
=====================
* Mike Cola
Avalo Therapeutics, Inc. - CEO & Chairman of the Board
* Schond Greenway
Avalo Therapeutics, Inc. - CFO
* Jeff Wilkins
Avalo Therapeutics, Inc. - Chief Medical Officer

=====================
Conference Call Participants
=====================
* Chris Howerton
Jefferies Group (Trades, Portfolio) LLC - Analyst

=====================
Chris Howerton - Jefferies Group (Trades,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot